Starjemza
NDC 0143-9169, ustekinumab-hmny, injection, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0143-9169
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761419
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9169 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- USTEKINUMAB45 mg/.5mL
Pharmacologic classes
Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0143-9169-01 | 00143916901 | .5 mL in 1 VIAL (0143-9169-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8b72aa27-82cc-4c1b-be43-8b50e5e3d737
Use it
Look up 0143-9169 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9169 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0143-9169. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.